-
FDA chimes in on albuterol shortage
In a March 8 Twitter thread, the FDA acknowledged it's aware of a potential drug supply disruption after Gurnee, Ill.-based Akorn Operating Co. closed in late February. -
Amoxicillin shortage continues as resupply dates are delayed again
An ongoing national shortage of amoxicillin has again been further exacerbated by resupply delays. -
Drugmaker to pull only preterm birth drug from market
Covis Pharma will stop selling Makena, the only FDA-approved drug to prevent preterm births, months after a panel voted 14-1 to retract the treatment, according to The Wall Street Journal. -
5 Ozempic updates
Ozempic, a diabetes treatment that has caught the attention of Elon Musk, TikTokers and WeightWatchers for its off-label use of weight loss, has landed in five recent headlines: -
Moderna may test its bird flu, mpox vaccines in humans in 2023
Moderna is eyeing testing two vaccine candidates, one for mpox and another for bird flu, in humans later this year, Bloomberg reported March 6. -
Cuban breaks into brand-name drug market
Mark Cuban Cost Plus Drug Co. has entered into an agreement with IBSA Pharma to sell Tirosint, a medication for hypothyroidism. It will be the first brand-name drug offered by Mr. Cuban's pharmacy. -
FDA to question popular decongestant's efficacy
An FDA advisory panel will discuss in April the efficacy of a popular over-the-counter decongestant, phenylephrine, amid concerns the oral drug does not work. -
Nephron making albuterol 'as fast as possible' amid shortage
In response to Akorn Operating Co.'s sudden closure, Nephron Pharmaceuticals told Becker's the company is working to boost supply of albuterol. -
'We're done': California cuts ties with Walgreens over abortion pills
California Gov. Gavin Newsom said the state will not do business with Walgreens following confusion over whether the pharmacy retailer will distribute abortion pills. -
FDA expects to rule on full approval for Alzheimer's drug by July
The FDA is set to decide whether to fully approve Leqembi, Eisai and Biogen's Alzheimer's treatment by July 6, CNBC reported March 6. -
American Diabetes Association puts Wegovy, Ozempic as preferred treatments
After years of promoting another drug, the American Diabetes Association updated its guidelines to put Wegovy and diabetes medication Ozempic as the preferred treatments for Type 2 diabetes, The Wall Street Journal reported March 5. -
5 pharmacy execs recently promoted to C-suite roles
Four health systems and hospitals have recently promoted pharmacy leaders: -
Illinois to probe drugmaker after it laid off hundreds
Illinois plans to investigate Akorn Operating Co. after the drugmaker laid off hundreds of workers in late February, according to The Center Square. -
Walgreens reverses plan to dispense abortion pills in some states
Walgreens will not dispense abortion pills in several states where they remain legal. The move comes in response to pressure from Republican attorneys general, who last month wrote a letter to the company threatening legal action if it begins dispensing the drugs, Politico reported March 3. -
Walgreens partners with DoorDash, Uber for fast HIV prescription delivery
Transportation has been cited as a persistent barrier to healthcare access for many across the U.S. In an effort to curb that, a new partnership between Walgreens, DoorDash and Uber will now offer same-day delivery of HIV drugs to any patient within 15 miles of the pharmacy. -
4 drugmakers short on methotrexate amid post-Roe restrictions
Nationwide shortages of rheumatoid arthritis drug methotrexate, which some pharmacies have restricted because it can cause pregnancy complications or miscarriage, continue as four prominent pharmaceutical companies report shortages. -
Before its fall, Akorn settled a lawsuit for $7.9M
Akorn Operating Co., a Gurnee, Ill.-based drugmaker that shut down in late February after years of manufacturing violations and dwindling finances, settled for $7.9 million in a lawsuit involving Medicare false claim allegations. -
Some pharmacies don't carry Ozempic — but not because of the shortage
Independent pharmacies across the country have stopped stocking diabetes drug Ozempic, a popular off-label weight loss aid, but not because of the ongoing shortages, NBC News reported March 2. -
Hard to swallow? An FDA-approved capsule that tracks, sends data
The FDA recently greenlit an Irish devicemaker's request to market its Pill Sense System, an ingestible capsule that winds its way through a patient's gastrointestinal tract, detects light wavelengths and wirelessly transmits data. -
Hospitals' albuterol supply may dip after drugmaker shuts down
After Gurnee, Ill.-based Akorn Operating Co. closed its operations in late February, hospitals are left with only one domestic supplier of liquid albuterol, an asthma treatment already in shortage.
Page 49 of 50